155 related articles for article (PubMed ID: 31166128)
1. Therapeutic effects of soluble guanylate cyclase stimulation on pulmonary hemodynamics and emphysema development in guinea pigs chronically exposed to cigarette smoke.
Paul T; Blanco I; Aguilar D; Tura-Ceide O; Bonjoch C; Smolders VF; Peinado VI; Barberà JA
Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L222-L234. PubMed ID: 31166128
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.
Weissmann N; Lobo B; Pichl A; Parajuli N; Seimetz M; Puig-Pey R; Ferrer E; Peinado VI; Domínguez-Fandos D; Fysikopoulos A; Stasch JP; Ghofrani HA; Coll-Bonfill N; Frey R; Schermuly RT; García-Lucio J; Blanco I; Bednorz M; Tura-Ceide O; Tadele E; Brandes RP; Grimminger J; Klepetko W; Jaksch P; Rodriguez-Roisin R; Seeger W; Grimminger F; Barberà JA
Am J Respir Crit Care Med; 2014 Jun; 189(11):1359-73. PubMed ID: 24738736
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease.
Paul T; Salazar-Degracia A; Peinado VI; Tura-Ceide O; Blanco I; Barreiro E; Barberà JA
PLoS One; 2018; 13(1):e0190628. PubMed ID: 29304131
[TBL] [Abstract][Full Text] [Related]
4. Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Seimetz M; Parajuli N; Pichl A; Bednorz M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Weissmann N
PLoS One; 2015; 10(6):e0129327. PubMed ID: 26058042
[TBL] [Abstract][Full Text] [Related]
5. Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation.
Peinado VI; Guitart M; Blanco I; Tura-Ceide O; Paul T; Barberà JA; Barreiro E
Am J Physiol Lung Cell Mol Physiol; 2023 May; 324(5):L677-L693. PubMed ID: 36881560
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil in a cigarette smoke-induced model of COPD in the guinea-pig.
Domínguez-Fandos D; Valdés C; Ferrer E; Puig-Pey R; Blanco I; Tura-Ceide O; Paul T; Peinado VI; Barberà JA
Eur Respir J; 2015 Aug; 46(2):346-54. PubMed ID: 25929951
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis.
Vij N; Chandramani-Shivalingappa P; Van Westphal C; Hole R; Bodas M
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C73-C87. PubMed ID: 27413169
[TBL] [Abstract][Full Text] [Related]
8. Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease.
Domínguez-Fandos D; Ferrer E; Puig-Pey R; Carreño C; Prats N; Aparici M; Musri MM; Gavaldà A; Peinado VI; Miralpeix M; Barberà JA
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):337-46. PubMed ID: 24032416
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylate cyclase stimulators in pulmonary hypertension.
Stasch JP; Evgenov OV
Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
[TBL] [Abstract][Full Text] [Related]
10. The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease.
Glynos C; Dupont LL; Vassilakopoulos T; Papapetropoulos A; Brouckaert P; Giannis A; Joos GF; Bracke KR; Brusselle GG
Am J Respir Crit Care Med; 2013 Oct; 188(7):789-99. PubMed ID: 23841447
[TBL] [Abstract][Full Text] [Related]
11. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
14. Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension.
Amirjanians M; Egemnazarov B; Sydykov A; Kojonazarov B; Brandes R; Luitel H; Pradhan K; Stasch JP; Redlich G; Weissmann N; Grimminger F; Seeger W; Ghofrani H; Schermuly R
Oncotarget; 2017 May; 8(18):29613-29624. PubMed ID: 28410199
[TBL] [Abstract][Full Text] [Related]
15. Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.
Becker-Pelster EM; Hahn MG; Delbeck M; Dietz L; Hüser J; Kopf J; Kraemer T; Marquardt T; Mondritzki T; Nagelschmitz J; Nikkho SM; Pires PV; Tinel H; Weimann G; Wunder F; Sandner P; Schuhmacher J; Stasch JP; Truebel HKF
Respir Res; 2022 Oct; 23(1):272. PubMed ID: 36183104
[TBL] [Abstract][Full Text] [Related]
16. Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo.
Alogna A; Schwarzl M; Manninger M; Hamdani N; Zirngast B; Kloth B; Steendijk P; Verderber J; Zweiker D; Westermann D; Blankenberg S; Maechler H; Tschöpe C; Linke WA; Marsche G; Pieske BM; Post H
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H669-H680. PubMed ID: 29727215
[TBL] [Abstract][Full Text] [Related]
17. Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
Koress C; Swan K; Kadowitz P
Curr Hypertens Rep; 2016 Apr; 18(5):42. PubMed ID: 27118316
[TBL] [Abstract][Full Text] [Related]
18. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
19. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
20. Effects of Sevoflurane on Hemodynamics and Inducible Nitric Oxide Synthase/Soluble Guanylate Cyclase Signaling Pathway in a Rat Model of Pulmonary Arterial Hypertension.
Qin G; Luo H; Yin X; Wang L; Zhang J; Cao Y; Zhang Z; Ye Z; Wang E
Anesth Analg; 2017 Jul; 125(1):184-189. PubMed ID: 28301419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
